ArticleRadiology case reports2026
Calcified liver metastases from medullary thyroid carcinoma in a Multiple Endocrine Neoplasia Type 2A patient.
Article in Radiology case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Calcified liver lesions encompass a broad differential diagnosis, with calcified hepatic granulomas being the most frequently encountered. We report a rare case of calcified hepatic metastases that were initially misinterpreted as hepatic granulomas. A 51-year-old patient with known Multiple Endocrine Neoplasia Type 2A had a history of medullary thyroid carcinoma treated surgically with total thyroidectomy and bilateral neck dissection in 2005. Serial CT scans obtained between 2010 to 2025 showed a few progressively enlarging calcified hepatic lesions that were initially misinterpreted as calcified hepatic granulomas. Due to persistently elevated tumor markers, a 18F-DOPA PET/CT was performed, which demonstrated increased radiotracer uptake of these lesions, suggesting they are metabolically active hepatic metastasis. MRI with Gadoxetate disodium also showed finding suggestive of hypervascular hepatic metastases. Diagnostic laparoscopy and histopathology confirmed the diagnosis of calcified hepatic metastasis from medullary thyroid carcinoma. This case emphasizes that hepatic calcifications, though often presumed benign, may occasionally represent other underlying pathologies such as metastatic disease. We hope to describe the imaging features of calcified hepatic metastases from medullary thyroid carcinoma, and the differentials of calcified hepatic lesions.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.